Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.

Erik Vakil Ajay Sheshadri Saadia A Faiz Dimpy P Shah Yayuan ZhuLiang LiJoumana Kmeid Jacques AzziAmulya BalaganiLara BashouraElla J Ariza-Heredia Roy F Chemaly

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2018)

Mortality is similarly high among HM patients without HCT and HCT recipients. High-grade immunodeficiency and detection of RSV from BAL fluid are associated with higher 60-day mortality.

Keyphrases

respiratory syncytial virus
respiratory tract
high grade
end stage renal disease
cardiovascular events
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
peritoneal dialysis
low grade
patient reported outcomes
cell cycle arrest
quantum dots
sensitive detection